UPDATE 1-European biotech firm BioNTech reverses course in early trading . Oct 10 - Shares of BioNTech SE tumbled nearly 12% in afternoon trade, erasing all its gains from earlier on Thursday, another sign of weakness in the IPO market after the collapse of WeWork's market debut.